Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -23.50p -17.87% 108.00p 102.00p 109.00p 116.00p 108.00p 116.00p 12,966 08:21:38
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -8.3 -6.4 - 137.08

Tiziana Share Discussion Threads

Showing 576 to 599 of 600 messages
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
28/9/2018
19:54
An offer like that for TILS would give us about 5 Euro, or £4 per share. I'll take that. Anybody got contacts at Roche?
osammyboy2
28/9/2018
16:50
Up to 655 million euro for a pre-clinical companyHTTps://www.tusktherapeutics.com/HTTps://globenewswire.com/news-release/2018/09/28/1586258/0/en/Tusk-Therapeutics-to-be-acquired-by-Roche.html
jpuff
26/9/2018
09:54
Antibody biotech Tiziana Life Sciences sets terms for $16 million Nasdaq IPORenaissance Capital, September 25, 2018, 09:30:00 AM EDT  Tiziana Life Sciences, which is developing antibody therapies to combat NASH, Crohn's disease, MS, and cancer, announced terms for its Nasdaq IPO on Tuesday. The London, United Kingdom-based company plans to raise $16 million by offering 1.575 million ADSs at $10.25, the as-converted price of its shares on London's AIM (symbol: TILS). At that price, Tiziana Life Sciences would command a fully diluted market value of $212 million.  The pre-revenue company was founded in 1998 and plans to list on the Nasdaq under the symbol TLSA. Laidlaw & Company (UK) is the sole bookrunner on the deal. Deal timing was not announced. The article Antibody biotech Tiziana Life Sciences sets terms for $16 million Nasdaq IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com
wageslave
25/9/2018
17:36
50 billion dollar market per year up for grabs.
stenick
30/8/2018
12:32
Found this on net about Milciclib and breast cancer. So much reasearch with good results. Why do things take so long. hxxps://etd.ohiolink.edu/pg_10?0::NO:10:P10_ETD_SUBID:152002
stenick
24/8/2018
08:08
There’s a vote of confidence!
stenick
23/8/2018
13:42
The word 'spray' has made this thread exciting again: Stenick - 16 Aug 2018 - 10:31 A nasal spray to combat Alzheimer's and others, absolutely brilliant!. This blood brain barrier seems to have been a stumbling block,but with Foralumab and Milciclib able to cross it, well what a game changers these will be and Foralumab being fully human. I'm no scientist but I can see the potential. Stenick - 26 Apr 2018 - 07:25 We did and I think we do have a chance of a return. 25p. To 240p to 80p and lots of ups and down in between is a traders dream surely. Nothing has changed they still have some potentially really good products, loads of money, and news to come, all with less than 150mill shares in issue. The crash and Beauforts going bust has not helped the share price I suspect. I'm still hopeful here as I like what I hear about Milciclib and the thought of using a nasal spray to combat auto immune dieseases is appealing to me let alone big pharma. I've recouped some losses and hope for a bit more here.
andrbea
22/8/2018
07:51
Who knows Asmo but with millions of dollars,hopefully,they can get on with getting to market. And with no money issues and only 200mill shares I can see a market cap of 4 to 8 hundred million £ quite achievable to start.
stenick
22/8/2018
07:35
Then can we expect a rise on a re-start, Sten. ?
asmodeus
21/8/2018
17:56
Still along way to go to match past highs, but the day they announce offering to nasdaq there will be a halt in trading
stenick
21/8/2018
16:23
I did sell some holding to cover initial outlay of course.
stenick
21/8/2018
15:39
No Asmodeus, I bought loads at the beginning , so no averaging down, just enjoying the ride with a company I balieve in and hopefully with loads to come.
stenick
21/8/2018
14:35
Have you bought more, Stenick?
asmodeus
21/8/2018
11:06
Shareholder’s resolutions have granted that about 45million shares can be offered to high worth individuals on Nasdaq If Tils starts at approx $2 that’s $90million dollars raised if all sold. Plenty to finance pipeline to market. So the higher share price we get to on Aim the the higher we start on Nasdaq, simples.
stenick
21/8/2018
10:53
Nasdaq listing is imminent I would imagine as it is now a more realistic price to float at, but hay onwards and upwards.
stenick
21/8/2018
09:30
That 14k+ trade at 8:46 is the largest in a while here.
recordz
20/8/2018
19:46
break even £29.05p
twodegrees
20/8/2018
12:10
How soon is the listing on the Nasdaq.? Going well anyway,volume is a lot more than normal aswell. Those recent DB's got this going by the looks of it.
recordz
20/8/2018
09:37
And he’s buying more! Hopefully we will hit the Nasdaq at well over a dollar as the minimum price on nasdaq is a dollar.
stenick
17/8/2018
11:17
The fact the Mr Cerrone has bought nearly 500000 is a good sign and I think there are a lot of options at around 85p which would bring some money in. I’m not worried about dilution at this stage even with nasdaq offering as the max shares with all options, warrants and nasdaq will stil be under 200mill, and with loads of money in bank from nasdaq.Exciting times ahead me thinks.
stenick
17/8/2018
11:01
I tend to agree. It's a risk for sure - we all know that - but they have a strong team and USA exposure, so a buyout could also happen at a big premium I feel. The shares are very illiquid so any big volume buys will send the price rocketing again IMHO. The opposite applies too of course.
jpuff
17/8/2018
10:57
If theses drugs are as good as they look £2.00 will be a distant memory.IMO.
stenick
17/8/2018
10:33
I daren't calculate my break-even point - having originally got into this share by buying Regen. And like jpuff, having had my fingers plus most of my body burned in the past, I too was too windy to take the opportunity to get back in until (too late?) this morning.
asmodeus
17/8/2018
10:06
My break even is also 200p. I'm confident we'll get there given patience. Wish I'd had the guts to average down a bit at 35p recently but the psychology of it is a real barrier when down so much eh!
jpuff
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20181018 08:17:45